{"_buckets": {"deposit": "7d54ec23-cec1-4ffa-a176-da93ed043855"}, "_deposit": {"id": "9859", "owners": [], "pid": {"revision_id": 0, "type": "depid", "value": "9859"}, "status": "published"}, "_oai": {"id": "oai:niigata-u.repo.nii.ac.jp:00009859", "sets": ["456", "948"]}, "item_7_alternative_title_1": {"attribute_name": "その他のタイトル", "attribute_value_mlt": [{"subitem_alternative_title": "The Newly Established Diagnostic Criteria of Diabetes Mellitus (Rapid Progress of Diagnosis and Treatment in Diabetes Mellitus)"}]}, "item_7_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2011-12", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "12", "bibliographicPageEnd": "651", "bibliographicPageStart": "648", "bibliographicVolumeNumber": "125", "bibliographic_titles": [{"bibliographic_title": "新潟医学会雑誌"}, {"bibliographic_title": "新潟医学会雑誌", "bibliographic_titleLang": "en"}]}]}, "item_7_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Diagnosis of diabetes mellitus Confirmation of chronic hyperglycemia is essential for the diagnosis of diabetes mellitus. When plasma glucose levels are used to determine the categories of glycemia, patients are classified as having a diabetes if they meet one of the following criteria: ((1)) fasting plasma glucose level of ≧ 126mg/dl; ((2)) 2-h value of ≧ 200mg/dl in 75g oral glucose tolerance test (OGTT) ; or ((3)) casual plasma glucose level of ≧ 200mg/dl. Normal type is defined as fasting plasma glucose level of \u003c110mg/dl and 2-h value \u003c 140mg/dl in OGTT. According to the current revision, in addition to the earlier listed plasma glucose values, hemoglobin A1c (HbAI1c) has been given a more prominent position as one of the diagnostic criteria. That is, ((4)) HbA1c ≧ 6.5% is now also considered to indicate diabetic type. The value of HbA1c, which is equivalent to the internationally used HbA1c (%) (HbA1c [NGSP]) defined by the NGSP (National Glycohemoglobin Standardization Program), is expressed by adding 0.4% to the HbAI1c (JDS) (%) defined by the Japan Diabetes Society (JDS).", "subitem_description_type": "Abstract"}]}, "item_7_full_name_3": {"attribute_name": "著者別名", "attribute_value_mlt": [{"nameIdentifiers": [{"nameIdentifier": "68097", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Yahata, Kazuaki"}]}]}, "item_7_publisher_7": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "新潟医学会"}]}, "item_7_select_19": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_select_item": "publisher"}]}, "item_7_source_id_11": {"attribute_name": "書誌レコードID", "attribute_value_mlt": [{"subitem_source_identifier": "AN00182415", "subitem_source_identifier_type": "NCID"}]}, "item_7_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "00290440", "subitem_source_identifier_type": "ISSN"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "八幡, 和明"}], "nameIdentifiers": [{"nameIdentifier": "68096", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2019-08-06"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "125(12)_648-651.pdf", "filesize": [{"value": "722.6 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 722600.0, "url": {"label": "125(12)_648-651.pdf", "url": "https://niigata-u.repo.nii.ac.jp/record/9859/files/125(12)_648-651.pdf"}, "version_id": "9dd141cc-b846-452a-95c9-09071c65ca44"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "diagnostic criteria", "subitem_subject_scheme": "Other"}, {"subitem_subject": "HbA1c (NGSP)", "subitem_subject_scheme": "Other"}, {"subitem_subject": "HbA1c (JDS)", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "jpn"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "departmental bulletin paper", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "1 新しい糖尿病の診断基準(糖尿病の診断と治療の急速な展開,第661回新潟医学会)", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "1 新しい糖尿病の診断基準(糖尿病の診断と治療の急速な展開,第661回新潟医学会)"}, {"subitem_title": "1 新しい糖尿病の診断基準(糖尿病の診断と治療の急速な展開,第661回新潟医学会)", "subitem_title_language": "en"}]}, "item_type_id": "7", "owner": "1", "path": ["456", "948"], "permalink_uri": "http://hdl.handle.net/10191/29323", "pubdate": {"attribute_name": "公開日", "attribute_value": "2014-07-29"}, "publish_date": "2014-07-29", "publish_status": "0", "recid": "9859", "relation": {}, "relation_version_is_last": true, "title": ["1 新しい糖尿病の診断基準(糖尿病の診断と治療の急速な展開,第661回新潟医学会)"], "weko_shared_id": null}